Literature DB >> 20214940

Centrally administered relaxin-3 induces Fos expression in the osmosensitive areas in rat brain and facilitates water intake.

Hiroki Otsubo1, Tatsushi Onaka, Hitoshi Suzuki, Akiko Katoh, Toyoaki Ohbuchi, Miwako Todoroki, Mizuki Kobayashi, Hiroaki Fujihara, Toru Yokoyama, Tetsuro Matsumoto, Yoichi Ueta.   

Abstract

The expression of the relaxin-3 gene, detected as a new member of the insulin superfamily using human genomic databases, is abundantly present in the brain and testis. Intracerebroventricularly (icv) administered relaxin-3 stimulates food intake. Icv administered relaxin (identical to relaxin-2 in humans) affects the secretion of vasopressin and drinking behavior. Relaxin-3 partly binds relaxin family peptide receptor 1, which is a specific receptor to relaxin. Thus, we hypothesized that relaxin-3 would have physiological effects in the body fluid balance. However, the effects of relaxin-3 in the body fluid balance remain unknown. In the present study, we revealed that icv administered relaxin-3 induced dense Fos-like immunoreactivity (Fos-LI) in the rat hypothalamus and circumventricular organs including the organum vasculosum of the lamina terminalis, the median preoptic nucleus, supraoptic nucleus (SON), the subfornical organ (SFO) and the paraventricular nucleus (PVN), that are related to the central regulation of body fluid balance. Icv administered relaxin-3 (54, 180 and 540 pmol/rat) also induced a significant increase in c-fos gene expression in a dose-dependent manner in the SON, SFO and PVN. Further, icv administered relaxin-3 (180 pmol/rat) significantly increased water intake, and the effect was as strong as that of relaxin-2 (180 pmol/rat). These results suggest that icv administered relaxin-3 activates osmosensitive areas in the brain and plays an important role in the regulation of body fluid balance. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214940     DOI: 10.1016/j.peptides.2010.02.020

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus.

Authors:  Yoshihisa Watanabe; Yasumasa Miyamoto; Tomoyuki Matsuda; Masaki Tanaka
Journal:  J Mol Neurosci       Date:  2010-11-12       Impact factor: 3.444

Review 2.  Neurohumoral Integration of Cardiovascular Function by the Lamina Terminalis.

Authors:  Nicole M Cancelliere; Emily A E Black; Alastair V Ferguson
Journal:  Curr Hypertens Rep       Date:  2015-12       Impact factor: 5.369

3.  Research resource: Gene profiling of G protein-coupled receptors in the arcuate nucleus of the female.

Authors:  Oline K Rønnekleiv; Yuan Fang; Chunguang Zhang; Casey C Nestor; Peizhong Mao; Martin J Kelly
Journal:  Mol Endocrinol       Date:  2014-06-16

4.  Intranasal administration of a stapled relaxin-3 mimetic has anxiolytic- and antidepressant-like activity in rats.

Authors:  Subhi Marwari; Anders Poulsen; Norrapat Shih; Rajamani Lakshminarayanan; R Manjunatha Kini; Charles William Johannes; Brian William Dymock; Gavin Stewart Dawe
Journal:  Br J Pharmacol       Date:  2019-09-11       Impact factor: 8.739

Review 5.  Central regulation of body fluid homeostasis.

Authors:  Masaharu Noda; Takashi Matsuda
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2022       Impact factor: 3.945

Review 6.  Relaxin-3/RXFP3 Signaling and Neuroendocrine Function - A Perspective on Extrinsic Hypothalamic Control.

Authors:  Despina E Ganella; Sherie Ma; Andrew L Gundlach
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-18       Impact factor: 5.555

Review 7.  Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Diego Rodríguez-Penas; Manuel Portolés; Esther Roselló-Lletí; Miguel Rivera; José R González-Juanatey; Francisca Lago
Journal:  Front Physiol       Date:  2017-08-18       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.